Carl Gommoll, MS
- 2Articles
- 20.8KReads1
- 2014–2016Active
- 9Collaborators
- 71Citations2
About
Carl Gommoll, MS, has contributed to research on the efficacy and safety of vilazodone in treating generalized anxiety disorder and major depressive disorder. His publications, appearing between 2014 and 2016, focus on anxiety, anxiolytics, and depression. Gommoll has frequently collaborated with co-authors including Maju Mathews, Rene Nunez, Dalei Chen, David V. Sheehan, and Giovanna Forero.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
